As of 2026-04-04, the Intrinsic Value of Sakar Healthcare Ltd (SAKAR.NS) is 78.38 INR. This SAKAR.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 515.30 INR, the upside of Sakar Healthcare Ltd is -84.80%.
The range of the Intrinsic Value is 50.81 - 132.78 INR
Based on its market price of 515.30 INR and our intrinsic valuation, Sakar Healthcare Ltd (SAKAR.NS) is overvalued by 84.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 50.81 - 132.78 | 78.38 | -84.8% |
| DCF (Growth 10y) | 140.29 - 303.93 | 195.64 | -62.0% |
| DCF (EBITDA 5y) | 365.61 - 522.93 | 388.65 | -24.6% |
| DCF (EBITDA 10y) | 409.31 - 638.84 | 460.55 | -10.6% |
| Fair Value | 178.28 - 178.28 | 178.28 | -65.40% |
| P/E | 101.19 - 215.60 | 156.23 | -69.7% |
| EV/EBITDA | 191.96 - 447.99 | 297.87 | -42.2% |
| EPV | (66.44) - (74.20) | (70.32) | -113.6% |
| DDM - Stable | 79.54 - 201.11 | 140.33 | -72.8% |
| DDM - Multi | 133.30 - 264.20 | 177.43 | -65.6% |
| Market Cap (mil) | 11,465.42 |
| Beta | 0.66 |
| Outstanding shares (mil) | 22.25 |
| Enterprise Value (mil) | 12,314.08 |
| Market risk premium | 8.31% |
| Cost of Equity | 11.52% |
| Cost of Debt | 7.56% |
| WACC | 11.14% |